EMAIL DETAILS
SUBJECT:
RE: mutual patient
PRI: NORMAL
FROM:
2
261penn@gmail.com
DATE:
2014-04-15 15:34:13
MSG_ID:
<1397576053322.2530ad9@Nodemailer>
RECIPIENTS:
TO:
J
Jon Glass
<jon.glass@jefferson.edu>
CC:
H
Olivere Hallie
<halliebiden@gmail.com>
H
Hunter Biden
<hbiden@rosemontseneca.com>
W
Yung,W K Alfred
<wyung@mdanderson.org>
CONTENT:
TEXT: YES |
HTML: YES
PROCESSED
Great. Anytime this week. Just let me know when. Confidentiality Notice: This electronic message and any attachment(s) are confidential and may be subject to the attorney/client privilege and/or work product immunity. This e-mail is only for the use of the intended recipient(s). If you have received this e-mail in error, please notify the sender immediately by replying to this e-mail, then delete this message and any attachment(s) from your system. Any unintended transmission expressly shall not waive the attorney/client privilege or any other privilege. On Tue, Apr 15, 2014 at 10:58 AM, Jon Glass <Jon.Glass@jefferson.edu> wrote: > ?Certainly. I will start the process. > J Glass > ________________________________ > From: Yung,W K Alfred <wyung@mdanderson.org> > Sent: Tuesday, April 15, 2014 10:08 AM > To: Jon Glass > Cc: Downey,Ginger > Subject: mutual patient > Jon, > The MRI yesterday showed about the same picture as in March. The nodular enhancement is slight less, but the spectroscopy of the posterior margin showed high choline. I am impressed with the degree of dysphasia he has. I am thinking of giving him 3-4 doses of Avastin to treat the necrosis so we can have a clearer picture of the background ?tumor progression. Can you arrange for the Avastin infusion? > I attached a summary of his MRI pictures here, and a CD is being FedEX to you. > Al > W.K. Alfred Yung, M.D. > Chairman, Department of Neuro-Oncology > Margaret and Ben Love Chair in Clinical Cancer Care > UT M. D. Anderson Cancer Center, Unit 431 > 1515 Holcombe Blvd > Houston, TX 77030 > Tele: 713-794-1285 > Fax: 713-563-0151 > wyung@mdanderson.org > The information contained in this transmission contains privileged and confidential information. It is intended only for the use of the person named above. If you are not the intended recipient, you are hereby notified that any review, dissemination, distribution or duplication of this communication is strictly prohibited. If you are not the intended recipient, please contact the sender by reply email and destroy all copies of the original message. > CAUTION: Intended recipients should NOT use email communication for emergent or urgent health care matter
METADATA:
THREAD:
INDEX:
AdhhqJucHJEEVanuStK3nJcNQVBtsA==
REFERENCES:
REPLY_TO:
<a153801eb15e4982b482985471c52389@BY2PR05MB742.namprd05.prod.outlook.com>
REFS:
<a153801eb15e4982b482985471c52389@BY2PR05MB742.namprd05.prod.outlook.com>